BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 34380537)

  • 1. Phosphorylation of NF-κBp65 drives inflammation-mediated hepatocellular carcinogenesis and is a novel therapeutic target.
    Xu X; Lei Y; Chen L; Zhou H; Liu H; Jiang J; Yang Y; Wu B
    J Exp Clin Cancer Res; 2021 Aug; 40(1):253. PubMed ID: 34380537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aerobic glycolysis enhances HBx-initiated hepatocellular carcinogenesis via NF-κBp65/HK2 signalling.
    Chen L; Lin X; Lei Y; Xu X; Zhou Q; Chen Y; Liu H; Jiang J; Yang Y; Zheng F; Wu B
    J Exp Clin Cancer Res; 2022 Nov; 41(1):329. PubMed ID: 36411480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. β-Arrestin1 enhances hepatocellular carcinogenesis through inflammation-mediated Akt signalling.
    Yang Y; Guo Y; Tan S; Ke B; Tao J; Liu H; Jiang J; Chen J; Chen G; Wu B
    Nat Commun; 2015 Jun; 6():7369. PubMed ID: 26077142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The chemokine receptor CCR10 promotes inflammation-driven hepatocarcinogenesis via PI3K/Akt pathway activation.
    Wu Q; Chen JX; Chen Y; Cai LL; Wang XZ; Guo WH; Zheng JF
    Cell Death Dis; 2018 Feb; 9(2):232. PubMed ID: 29445190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. β-Arrestin1 is involved in hepatocellular carcinoma metastasis via extracellular signal-regulated kinase-mediated epithelial-mesenchymal transition.
    Xu X; Lei Y; Zhou H; Guo Y; Liu H; Jiang J; Yang Y; Wu B
    J Gastroenterol Hepatol; 2020 Dec; 35(12):2229-2240. PubMed ID: 32445259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HBx induces hepatocellular carcinogenesis through ARRB1-mediated autophagy to drive the G
    Lei Y; Xu X; Liu H; Chen L; Zhou H; Jiang J; Yang Y; Wu B
    Autophagy; 2021 Dec; 17(12):4423-4441. PubMed ID: 33866937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EYA4 inhibits hepatocellular carcinoma growth and invasion by suppressing NF-κB-dependent RAP1 transactivation.
    Mo SJ; Hou X; Hao XY; Cai JP; Liu X; Chen W; Chen D; Yin XY
    Cancer Commun (Lond); 2018 Apr; 38(1):9. PubMed ID: 29764501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic NOD2 promotes hepatocarcinogenesis via a RIP2-mediated proinflammatory response and a novel nuclear autophagy-mediated DNA damage mechanism.
    Zhou Y; Hu L; Tang W; Li D; Ma L; Liu H; Zhang S; Zhang X; Dong L; Shen X; Chen S; Xue R; Zhang S
    J Hematol Oncol; 2021 Jan; 14(1):9. PubMed ID: 33413510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bile acids promote diethylnitrosamine-induced hepatocellular carcinoma via increased inflammatory signaling.
    Sun L; Beggs K; Borude P; Edwards G; Bhushan B; Walesky C; Roy N; Manley MW; Gunewardena S; O'Neil M; Li H; Apte U
    Am J Physiol Gastrointest Liver Physiol; 2016 Jul; 311(1):G91-G104. PubMed ID: 27151938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abberent expression of NOR1 protein in tumor associated macrophages contributes to the development of DEN-induced hepatocellular carcinoma.
    Chen S; Zheng P; Wang W; Yi M; Chen P; Cai J; Li J; Peng Q; Ban Y; Zhou Y; Zeng Z; Li X; Xiong W; Li G; Xiang B
    J Cell Physiol; 2018 Jun; 233(6):5002-5013. PubMed ID: 29227538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SPTBN1 inhibits inflammatory responses and hepatocarcinogenesis via the stabilization of SOCS1 and downregulation of p65 in hepatocellular carcinoma.
    Lin L; Chen S; Wang H; Gao B; Kallakury B; Bhuvaneshwar K; Cahn K; Gusev Y; Wang X; Wu Y; Marshall JL; Zhi X; He AR
    Theranostics; 2021; 11(9):4232-4250. PubMed ID: 33754058
    [No Abstract]   [Full Text] [Related]  

  • 12. TNF-α/NF-κB signaling epigenetically represses PSD4 transcription to promote alcohol-related hepatocellular carcinoma progression.
    Shi J; Song S; Li S; Zhang K; Lan Y; Li Y
    Cancer Med; 2021 May; 10(10):3346-3357. PubMed ID: 33932127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandin E2 accelerates invasion by upregulating Snail in hepatocellular carcinoma cells.
    Zhang M; Zhang H; Cheng S; Zhang D; Xu Y; Bai X; Xia S; Zhang L; Ma J; Du M; Wang Y; Wang J; Chen M; Leng J
    Tumour Biol; 2014 Jul; 35(7):7135-45. PubMed ID: 24760275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NKILA, a prognostic indicator, inhibits tumor metastasis by suppressing NF-κB/Slug mediated epithelial-mesenchymal transition in hepatocellular carcinoma.
    Chen R; Cheng Q; Owusu-Ansah KG; Song G; Jiang D; Zhou L; Xu X; Wu J; Zheng S
    Int J Biol Sci; 2020; 16(3):495-503. PubMed ID: 32015685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-595 suppresses cell proliferation and metastasis in hepatocellular carcinoma by inhibiting NF-κB signalling pathway.
    Wang H; Jiang F; Liu W; Tian W
    Pathol Res Pract; 2020 Apr; 216(4):152899. PubMed ID: 32107085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TREM-2 defends the liver against hepatocellular carcinoma through multifactorial protective mechanisms.
    Esparza-Baquer A; Labiano I; Sharif O; Agirre-Lizaso A; Oakley F; Rodrigues PM; Zhuravleva E; O'Rourke CJ; Hijona E; Jimenez-Agüero R; Riaño I; Landa A; La Casta A; Zaki MYW; Munoz-Garrido P; Azkargorta M; Elortza F; Vogel A; Schabbauer G; Aspichueta P; Andersen JB; Knapp S; Mann DA; Bujanda L; Banales JM; Perugorria MJ
    Gut; 2021 Jul; 70(7):1345-1361. PubMed ID: 32907830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor necrosis factor α-induced protein 1 as a novel tumor suppressor through selective downregulation of CSNK2B blocks nuclear factor-κB activation in hepatocellular carcinoma.
    Xiao Y; Huang S; Qiu F; Ding X; Sun Y; Wei C; Hu X; Wei K; Long S; Xie L; Xun Y; Chen W; Zhang Z; Liu N; Xiang S
    EBioMedicine; 2020 Jan; 51():102603. PubMed ID: 31901862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nimbolide inhibits tumor growth by restoring hepatic tight junction protein expression and reduced inflammation in an experimental hepatocarcinogenesis.
    Ram AK; Vairappan B; Srinivas BH
    World J Gastroenterol; 2020 Dec; 26(45):7131-7152. PubMed ID: 33362373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-127-5p targets the biliverdin reductase B/nuclear factor-κB pathway to suppress cell growth in hepatocellular carcinoma cells.
    Huan L; Bao C; Chen D; Li Y; Lian J; Ding J; Huang S; Liang L; He X
    Cancer Sci; 2016 Mar; 107(3):258-66. PubMed ID: 26708147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IGFBP2 upregulates ZEB1 expression and promotes hepatocellular carcinoma progression through NF-κB signaling pathway.
    Guo Q; Yu DY; Yang ZF; Liu DY; Cao HQ; Liao XW
    Dig Liver Dis; 2020 May; 52(5):573-581. PubMed ID: 31818638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.